Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study (Q33880138)

29 July 2017

title

Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study (English)

1 reference

29 July 2017

1 reference

1 reference

Hasniza Zaman Huri

1

1 reference

29 July 2017

Tee Lian Choo

2

1 reference

29 July 2017

Che Zuraini Sulaiman

3

1 reference

29 July 2017

Raymond Mark

4

1 reference

29 July 2017

Azad Hassan Abdul Razack

5

1 reference

29 July 2017

publication date

7 July 2014

1 reference

29 July 2017

1 reference

29 July 2017

volume

4

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

e005381

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

29 July 2017

1 reference

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

The Third National Health and Morbidity Survey: prevalence of obesity, and abdominal obesity among the Malaysian elderly population

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Defining comorbidity: implications for understanding health and health services

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

5-alpha reductase inhibitors and erectile dysfunction: the connection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Erectile dysfunction: clinical guidelines (1).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Chapter 1: The management of erectile dysfunction: an AUA update

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Hypogonadism and erectile dysfunction: the role for testosterone therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091539

Definition and classification of erectile dysfunction: report of the Nomenclature Committee of the International Society of Impotence Research

28 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Predictors and prevalence of erectile dysfunction in a racially diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

EAU Guidelines on erectile dysfunction: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Effect of tamsulosin on ejaculatory function in BPH/LUTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

A prospective study of risk factors for erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Low levels of androgens in men with erectile dysfunction and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: Results of a regional population-based survey and comparison with industrialized nations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005381

An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.

21 January 2018

1 reference

12 December 2020

Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms

1 reference

12 December 2020

Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial

1 reference

12 December 2020

Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries

1 reference

12 December 2020

Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Prevalence of cardiovascular risk factors in a rural community in mukim dengkil, selangor

1 reference

12 December 2020

10.1136/BMJOPEN-2014-005381

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference